ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 128 filers reported holding ANI PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $15,538 | -7.9% | 244 | 0.0% | 0.00% | 0.0% |
| Q1 2024 | $16,868 | +25.4% | 244 | 0.0% | 0.00% | 0.0% |
| Q4 2023 | $13,454 | -99.9% | 244 | -99.9% | 0.00% | -99.8% |
| Q3 2023 | $10,118,523 | +7.9% | 174,277 | +0.0% | 0.49% | +19.5% |
| Q2 2023 | $9,381,277 | -36.7% | 174,276 | -53.3% | 0.41% | -42.3% |
| Q1 2023 | $14,831,686 | -16.8% | 373,406 | -15.8% | 0.71% | -17.5% |
| Q4 2022 | $17,831,384 | +21.5% | 443,236 | -3.0% | 0.86% | +13.9% |
| Q3 2022 | $14,680,000 | +8.5% | 456,748 | +0.2% | 0.76% | +8.9% |
| Q2 2022 | $13,526,000 | +35.9% | 455,880 | +28.8% | 0.70% | +83.4% |
| Q1 2022 | $9,952,000 | +160.4% | 354,045 | +326.8% | 0.38% | +168.8% |
| Q4 2021 | $3,822,000 | +17.1% | 82,944 | -28.1% | 0.14% | -27.3% |
| Q3 2014 | $3,265,000 | -16.3% | 115,440 | +1.9% | 0.19% | -11.8% |
| Q2 2014 | $3,902,000 | +72.8% | 113,290 | +57.3% | 0.22% | +73.2% |
| Q1 2014 | $2,258,000 | – | 72,020 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 326,778 | $20,152,000 | 2.95% |
| Hawk Ridge Capital Management | 188,761 | $11,641,000 | 1.89% |
| Global Alpha Capital Management Ltd. | 169,746 | $10,468,000 | 1.55% |
| Mesirow Financial Investment Management, Inc. | 5,723 | $353,000 | 1.49% |
| 1492 Capital Management LLC | 25,093 | $1,547,000 | 1.37% |
| THB ASSET MANAGEMENT | 91,018 | $5,613,000 | 1.04% |
| Regent Investment Management LLC | 41,329 | $2,549,000 | 0.78% |
| Phocas Financial Corp. | 101,567 | $6,263,000 | 0.75% |
| INVESTMENT COUNSELORS OF MARYLAND LLC | 284,334 | $17,535,000 | 0.75% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 35,500 | $2,189,000 | 0.70% |